Biomarkers of Cardioembolic Stroke in Thrombus Composition: Diagnostic Value of <scp>DNA</scp> and Fibrin Content
DNA and fibrin content in thrombi are promising biomarkers for identifying cardioembolic stroke etiology. Prospective studies should evaluate their use in selecting ESUS patients who may benefit from anticoagulant therapy.
Authors
- Mialitiana Solo Nomenjanahary
- Lucas Di Meglio (ORCID: https://orcid.org/0000-0002-5158-8612)
- Dorothée Faille (ORCID: https://orcid.org/0000-0003-4414-739X)
- Laurine Bedoucha
- M Piotin
- Capucine Habay (ORCID: https://orcid.org/0009-0003-6225-2959)
- Julien Labreuche
- Jéromine Fasille
- Arturo Consoli
- Maeva Kyheng
- Mikael Mazighi
- the Compo CLOT Study Group
- Bertrand Lapergue
Institutions
- Inserm (FR)
- Université Sorbonne Nouvelle (FR)
- Institut Universitaire de France (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris Cité (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Sorbonne Université (FR)
- Hôpital Lariboisière (FR)
- Fondation de Rothschild (FR)
- FHU Neurovasc (FR)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/ene.70484
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00